Enzyme-Linked Immunosorbent Assay (ELISA)
At Medtechtomarket, we support the development, optimisation, and translation of ELISA-based assays for a broad range of clinical applications — from infectious disease testing to cancer biomarker detection.
Key ELISA Capabilities:
- Assay development and optimisation from concept to regulatory approval
- Custom antigen and antibody sourcing or generation, including recombinant options
- Platform miniaturisation or adaptation for semi-automated and high-throughput systems
- Analytical and clinical validation to ISO 13485:2016 standards
- Manufacturing support for ELISA components or complete kits
- Interpretive software for analysis and quantification
Typical ELISA Applications:
- Quantification of protein biomarkers in blood, serum, saliva, or urine
- Detection of antibodies or antigens in infectious disease diagnostics
- Use as a reference or confirmatory method in broader diagnostic workflows
Medtechtomarket is a trusted CDMO partner for the development and manufacture of assays, working with Universities, Industry and Investors to develop technologies within our 12,000 sq. ft custom built biohazardous laboratories and manufacturing facility. We can accommodate most sample matrices, applications, or budgets.